TY  - GEN
AU  - Gargini, Ricardo
AU  - Segura-Collar, Berta
AU  - Garranzo-Asensio, Maria
AU  - Hortigüela, Rafael
AU  - Iglesias-Hernandez, Patricia
AU  - Lobato-Alonso, Daniel
AU  - Moreno-Raja, Miguel
AU  - Esteban-Martin, Santiago
AU  - Sepúlveda-Sánchez, Juan M
AU  - Nevola, Laura
AU  - Sánchez-Gómez, Pilar
PY  - 2022
DO  - 10.1007/s13311-021-01176-6
UR  - https://hdl.handle.net/20.500.12105/27160
AB  - Glioblastomas (GBMs) are the most frequent and highly aggressive brain tumors, being resistant to all cytotoxic and molecularly targeted agents tested so far. There is, therefore, an urgent need to find novel therapeutic approaches and/or alternative...
LA  - eng
PB  - https://doi.org/10.1007/s13311-021-01176-6
KW  - Angiogenesis
KW  - Glioblastoma
KW  - Glioma
KW  - N-MYC
KW  - Peptide inhibitors
KW  - Protein stability
KW  - Tumor microenvironment
TI  - IDP-410: a Novel Therapeutic Peptide that Alters N-MYC Stability and Reduces Angiogenesis and Tumor Progression in Glioblastomas.
TY  - research article
ER  -